Pharmaceutical Industry in Gujarat Sounds Alarm Over LPG Shortage Crisis
Several pharmaceutical companies in Ahmedabad have raised urgent concerns about the unavailability of industrial LPG cylinders, which they say is threatening the production of life-saving medicines. The industry has formally requested the Gujarat government to intervene and ensure an uninterrupted supply of gas cylinders, warning that continued shortages could severely impact supplies to hospitals and healthcare facilities across the region.
Industry Body Issues Formal Warning to State Government
Pathik Patwari, chairman of the Gujarat chapter of the Indian Chamber of Commerce (ICC), has written to the state government detailing the critical situation. According to the communication, multiple drug manufacturers are experiencing irregular supply of industrial LPG cylinders, which are essential for sealing ampoules used in injectable medicines. The industry body revealed that some companies have stock remaining for only a few more days of operations before production would need to be halted entirely.
Critical Medicines at Risk of Production Disruption
The medicines whose production could be affected are widely used in hospitals and healthcare facilities for treating serious medical conditions. These include medications for:
- Malaria and falciparum infections
- Metabolic acidosis
- Nausea and vomiting, particularly after surgical procedures or chemotherapy treatments
These medications represent essential components of hospital treatment protocols and their shortage could have significant consequences for patient care.
Technical Requirements for Medicine Production
According to ICC specifications, manufacturers require at least 10 industrial LPG cylinders of 19kg each every month for regular production. These cylinders are used in conjunction with oxygen to generate the high-temperature flame necessary for hermetically sealing single-dose glass ampoules after filling. This process is absolutely essential for maintaining sterility and product integrity in injectable medicines.
An anonymous director of a pharmaceutical company stated, "Any prolonged disruption in LPG cylinder availability can directly impact the production of medicines. If we do not receive LPG cylinders, we will have to stop production of some critical medicines from Saturday." This statement underscores the immediacy of the crisis facing the industry.
Call for Government Intervention Based on Pandemic Precedent
Patwari highlighted that during the COVID-19 pandemic, manufacturers of essential medicines were given priority access to industrial gases to prevent shortages of critical drugs. He emphasized that a similar approach is needed now to protect the supply chain for life-saving medications. The industry is requesting that the Gujarat government implement measures to ensure pharmaceutical companies receive priority allocation of industrial LPG cylinders, similar to the emergency protocols established during the health crisis.
The pharmaceutical industry's warning comes at a time when healthcare systems are already under pressure, making the potential disruption to medicine supplies particularly concerning. Industry representatives stress that timely government intervention is crucial to prevent what could become a public health emergency if critical medicines become unavailable to hospitals and patients who depend on them for treatment and recovery.
